newsfilter
← Latest News
FDA Approved Drugs·

Approval of Wellbutrin Xl, Nda #021515 (Labeling)

Approval Date: 11/05/2025; Drug Name: Wellbutrin Xl, Nda #021515; Active Ingredients: BUPROPION HYDROCHLORIDE; Company: Bausch; Submission Status: Approval; Submission Classification: Labeling; Application Number: 021515

Company
BAUSCH
Keywords
BAUSCH